DK1225174T3 - Vandfri mirtazapinkrystaller og fremgangsmåde til fremstilling deraf - Google Patents

Vandfri mirtazapinkrystaller og fremgangsmåde til fremstilling deraf

Info

Publication number
DK1225174T3
DK1225174T3 DK00962908T DK00962908T DK1225174T3 DK 1225174 T3 DK1225174 T3 DK 1225174T3 DK 00962908 T DK00962908 T DK 00962908T DK 00962908 T DK00962908 T DK 00962908T DK 1225174 T3 DK1225174 T3 DK 1225174T3
Authority
DK
Denmark
Prior art keywords
crystals
anhydrous mirtazapine
mirtazapine crystals
preparation
anhydrous
Prior art date
Application number
DK00962908T
Other languages
Danish (da)
English (en)
Inventor
Eiichi Iishi
Yoshiyuki Imamiya
Original Assignee
Sumika Fine Chemicals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26574376&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1225174(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sumika Fine Chemicals Co Ltd filed Critical Sumika Fine Chemicals Co Ltd
Application granted granted Critical
Publication of DK1225174T3 publication Critical patent/DK1225174T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK00962908T 1999-11-24 2000-09-28 Vandfri mirtazapinkrystaller og fremgangsmåde til fremstilling deraf DK1225174T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP33304999 1999-11-24
JP2000067476 2000-03-10
PCT/JP2000/004835 WO2001038329A1 (fr) 1999-11-24 2000-07-19 Cristaux de mirtazapine anhydre et leur procede d'obtention
PCT/JP2000/006687 WO2001038330A1 (fr) 1999-11-24 2000-09-28 Cristaux de mirtazapine anhydres et leur procede de fabrication

Publications (1)

Publication Number Publication Date
DK1225174T3 true DK1225174T3 (da) 2004-07-05

Family

ID=26574376

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00962908T DK1225174T3 (da) 1999-11-24 2000-09-28 Vandfri mirtazapinkrystaller og fremgangsmåde til fremstilling deraf

Country Status (11)

Country Link
US (3) US6552189B2 (ja)
EP (1) EP1225174B2 (ja)
JP (1) JP3699680B2 (ja)
AT (1) ATE261966T1 (ja)
AU (2) AU6019900A (ja)
CA (1) CA2370376C (ja)
DE (1) DE60009117T2 (ja)
DK (1) DK1225174T3 (ja)
ES (1) ES2214318T5 (ja)
PT (1) PT1225174E (ja)
WO (2) WO2001038329A1 (ja)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6019900A (en) * 1999-11-24 2001-06-04 Sumika Fine Chemicals Co., Ltd. Anhydrous mirtazapine crystals and process for producing the same
US7838029B1 (en) 2003-07-31 2010-11-23 Watson Laboratories, Inc. Mirtazapine solid dosage forms
EP1689371A2 (en) * 2003-11-25 2006-08-16 Aurobindo Pharma Limited Pharmaceutical compositions of mirtazapine
EP1688410B1 (en) 2003-11-27 2014-03-05 Ajinomoto Co., Inc. Crystal of phenylalanine derivative and process for producing the same
US20060039866A1 (en) * 2004-08-20 2006-02-23 Cypress Bioscience, Inc. Method for treating sleep-related breathing disorders
JP5192707B2 (ja) 2007-03-22 2013-05-08 住友化学株式会社 ミルタザピンの製造方法
JP5364088B2 (ja) * 2007-04-05 2013-12-11 アクゾ ノーベル ナムローゼ フェンノートシャップ 紙の光学的性質を改良する方法
CA2704117C (en) * 2007-11-02 2015-11-17 Acrux Dds Pty Ltd Transdermal delivery system
CN103520169B (zh) * 2013-10-25 2015-07-15 山东鲁药制药有限公司 米氮平片及其制备方法
US10603272B2 (en) 2015-02-27 2020-03-31 Kindred Biosciences, Inc. Stimulation of appetite and treatment of anorexia in dogs and cats
JP6452575B2 (ja) * 2015-08-19 2019-01-16 株式会社トクヤマ ミルタザピンの製造方法
JP2017088564A (ja) * 2015-11-13 2017-05-25 株式会社トクヤマ ミルタザピンの製造方法
JP6571497B2 (ja) * 2015-11-13 2019-09-04 株式会社トクヤマ ミルタザピンの製造方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL189199C (nl) * 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
US4524146A (en) * 1982-12-08 1985-06-18 Ciba-Geigy Corporation Certain -2-heterocycle substituted pyrazoloquinolines
NZ230711A (en) * 1988-09-23 1990-10-26 Ortho Pharma Corp Substituted thienopyrans as antihypertensive agents
US5354763A (en) * 1993-11-17 1994-10-11 American Home Products Corporation Substituted N-heteroaryl and N-aryl-1,2-diaminocyclobutene-3,4-diones
US5468768A (en) * 1994-01-06 1995-11-21 Bristol-Myers Squibb Company Antimigraine derivatives of indolylcycloalkanylamines
JPH07247286A (ja) * 1994-01-18 1995-09-26 Sankyo Co Ltd 含窒素環状化合物の光学分割方法
CZ20013658A3 (cs) * 1999-04-19 2002-08-14 Teva Pharmaceutical Industries Ltd. Syntéza a krystalizace sloučenin obsahujících piperazinový kruh
US6545149B2 (en) 1999-04-19 2003-04-08 Teva Pharmaceutical Industries Ltd. Synthesis and crystallization of piperazine ring-containing compounds
AU6019900A (en) * 1999-11-24 2001-06-04 Sumika Fine Chemicals Co., Ltd. Anhydrous mirtazapine crystals and process for producing the same
US20020072602A1 (en) 2000-07-07 2002-06-13 Claude Singer Micronized mirtazapine
US6660730B2 (en) * 2000-11-27 2003-12-09 Sumika Fine Chemicals Co., Ltd. Anhydrous mirtazapine and process for preparing the same

Also Published As

Publication number Publication date
EP1225174A1 (en) 2002-07-24
US20020103372A1 (en) 2002-08-01
EP1225174B2 (en) 2010-06-02
PT1225174E (pt) 2004-05-31
WO2001038329A1 (fr) 2001-05-31
CA2370376C (en) 2005-08-02
US20040138447A1 (en) 2004-07-15
ES2214318T5 (es) 2010-10-15
DE60009117T2 (de) 2004-10-21
US20030130504A1 (en) 2003-07-10
US6723845B2 (en) 2004-04-20
AU763502B2 (en) 2003-07-24
JP3699680B2 (ja) 2005-09-28
CA2370376A1 (en) 2001-05-31
ATE261966T1 (de) 2004-04-15
AU6019900A (en) 2001-06-04
US6552189B2 (en) 2003-04-22
EP1225174A4 (en) 2002-10-23
DE60009117D1 (de) 2004-04-22
WO2001038330A1 (fr) 2001-05-31
AU7447100A (en) 2001-06-04
US7297790B2 (en) 2007-11-20
EP1225174B1 (en) 2004-03-17
ES2214318T3 (es) 2004-09-16

Similar Documents

Publication Publication Date Title
DK1225174T3 (da) Vandfri mirtazapinkrystaller og fremgangsmåde til fremstilling deraf
DE60307179D1 (de) Vor UV-Strahlen schützende Zusammensetzungen
DK1613304T3 (da) DPP-IV-inhibitorer
NO20055226L (no) Fremgangsmate for fremstilling av N-substituerte 2-cyanopyrrolidoner
DK0635499T3 (da) Nye acaricidt aktive tetrazinderivater
HUP0201357A2 (hu) Aszimmetrikus rézkomplex, előállítása, és eljárás ciklopropánkarbonsav-észter-származékok előállítására felhasználásával
ATE275572T1 (de) Malto-oligosaccharid-derivate und ihre anwendungen
WO2000064902A3 (en) Process for the preparation of calanolide precursors
HUP0202293A2 (hu) Új N-benzilpiperazin vegyületek, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények
DE60029245D1 (de) Verfahren zur herstellung von aryltriazolinonen
NO860114L (no) Imidazolderivater og fremgangsmaate til fremstilling derav.
HUP0500796A2 (hu) Új eljárás a flukonazol-monohidrát és a flukonazol kristálymódosulatai előállítására
DE50206142D1 (de) Verfahren zur herstellung von 1,3-disubstituierten 2-nitroguanidinen
EP1391450A4 (en) N- (HETEROCYCLYLMETHYL) ALKYLAMINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND BACTERICIDE
NO20010332L (no) Nye derivater av 6-deoksyerytromycin, deres fremstillingsprosess og deres anvendelse som medikamenter
DK1565479T3 (da) 2'-O-Trisubstitueret silyloxymethyl-ribonucleosid-derivat og fremgangsmåde til fremstilling deraf
DK1242390T3 (da) Fremgangsmåde til fremstilling af 1,3-disubstituerede 2-nitroguanidiner
TH40475A3 (th) กรรมวิธีสำหรับการเตรียมอนุพันธ์ ออร์โท-อัลคิเลทด์ เบนโซอิก แอซิด